Andexanet Aids Hemostasis in ICH Tied to FXa Inhibitors

While the new drug reduced hematoma expansion compared with usual care, it was also associated with an increase in thrombotic events in the ANNEXa-I study.

Related Keywords

Edinburgh ,City Of ,United Kingdom ,Toronto ,Ontario ,Canada ,Scotland ,Ashkan Shoamanesh ,Rustam Al Shahi Salman ,Stuart Connolly ,Andexxa Ondexxya ,Astrazeneca ,Mcmaster University ,National Institutes Of Health Stroke Scale ,World Stroke Congress ,University Of Edinburgh ,National Institutes ,Health Stroke Scale ,Rankin Scale ,Medscape Cardiology ,Al Shahi Salman ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Thromboembolism ,Factor Xa Inhibitors ,Hemorrhagic Stroke ,Intracranial Hemorrhage ,Intracranial Bleeding ,Brain Hemorrhage ,Brain Bleeding ,Leeding Brain ,Stroke Risk ,Hypertensive Brain Hemorrhage ,Ypertensive Brain Bleeding ,Myocardial Infarction ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,Hx Of Cerebrovascular Accident ,C ,